Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery Cytokeratin 15
Path
Created with Sketch.
Go to Cytokeratin 15 Normal Tissue Gallery
Go back to Product Page
Breast - Invasive breast cancer of no special type (NST) showing moderate to strong CK15 immunostaining in tumor cells.
Breast – Invasive breast cancer of no special type (NST) showing moderate to strong CK15 immunostaining in tumor cells.
Breast - Strong CK15 immunostaining of all cells of an invasive lobular breast cancer.
Breast – Strong CK15 immunostaining of all cells of an invasive lobular breast cancer.
Breast - Weak to moderate CK15 immunostaining in the majority of cells of an invasive breast cancer of no special type (NST).
Breast – Weak to moderate CK15 immunostaining in the majority of cells of an invasive breast cancer of no special type (NST).
Esophagus - Squamous cell carcinoma showing strong CK15 immunostaining.
Esophagus – Squamous cell carcinoma showing strong CK15 immunostaining.
Kidney - Cytokeratin 15 negative clear cell renal cell carcinoma.
Kidney – Cytokeratin 15 negative clear cell renal cell carcinoma.
Liver - Cholangiocellular carcinoma showing weak to moderate CK15 immunostaining in most tumor cells.
Liver – Cholangiocellular carcinoma showing weak to moderate CK15 immunostaining in most tumor cells.
Lung - Moderate to strong CK15 immunostaining in a pulmonary adenocarcinoma.
Lung – Moderate to strong CK15 immunostaining in a pulmonary adenocarcinoma.
Lung - Squamous cell carcinoma showing strong CK15 immunostaining.
Lung – Squamous cell carcinoma showing strong CK15 immunostaining.
Oral cavity - Squamous cell carcinoma with strong CK15 staining.
Oral cavity – Squamous cell carcinoma with strong CK15 staining.
Ovary - Brenner tumor showing moderate Cytokertin 15 staining in tumor cells.
Ovary – Brenner tumor showing moderate Cytokertin 15 staining in tumor cells.
Pancreas - Cytokeratin 15 negative neuroendocrine tumor.
Pancreas – Cytokeratin 15 negative neuroendocrine tumor.
Prostate - Cytokeratin 15 negative prostatic adenocarcinoma (Gleason 3+3=6). Few normal glands show staining of basal cells.
Prostate – Cytokeratin 15 negative prostatic adenocarcinoma (Gleason 3+3=6). Few normal glands show staining of basal cells.
Skin - Basal cell carcinoma with strong CK15 immunostaining.
Skin – Basal cell carcinoma with strong CK15 immunostaining.
Skin - Cytokeratin 15 negative Merkel cell carcinoma.
Skin – Cytokeratin 15 negative Merkel cell carcinoma.
Skin - Squamous cell carcinoma showing strong CK15 immunostaining.
Skin – Squamous cell carcinoma showing strong CK15 immunostaining.
Stomach- Cytokeratin negative gastric adenocarcinoma (intestinal type).
Stomach- Cytokeratin negative gastric adenocarcinoma (intestinal type).
Testis - Cytokeratin 15 negative seminoma.
Testis – Cytokeratin 15 negative seminoma.
Urinary bladder - Strong Cytokeratin 15 positivity in a muscle-invasive urothelial carcinoma.
Urinary bladder – Strong Cytokeratin 15 positivity in a muscle-invasive urothelial carcinoma.
Vagina - Squamous cell carcinoma showing strong CK15 immunostaining.
Vagina – Squamous cell carcinoma showing strong CK15 immunostaining.
Vulva - Squamous cell carcinoma with strong CK15 positivity.
Vulva – Squamous cell carcinoma with strong CK15 positivity.